论文部分内容阅读
目的探究溶栓与常规药物治疗急性心肌梗死的临床疗效。方法选取2011年2月～9月我院收治的100例急性心肌梗死患者,采取随机抽选的方式将研究对象分为对照组与研究组各50例,对照组给予常规药物治疗,研究组给予溶栓治疗,比较两组的临床疗效。结果对照组动脉再通率为58%,研究组动脉再通率为76%,研究组动脉再通率明显高于对照组;对照组用药后出现并发症16例,死亡5例,研究组用药后出现并发症9例,死亡3例,研究组用药后出现并发症与死亡例数均低于对照组,两组相比,差异存在统计学意义(P<0.05)。结论与常规药物治疗相比,溶栓治疗急性心肌梗死的临床疗效较为显著,值得推广使用。
Objective To investigate the clinical efficacy of thrombolytic therapy and conventional drugs in the treatment of acute myocardial infarction. Methods A total of 100 acute myocardial infarction patients admitted to our hospital from February to September in 2011 were randomly divided into control group and study group with 50 cases in each group. The control group was given conventional drug treatment and the study group was given Thrombolytic therapy, the clinical efficacy of the two groups were compared. Results In the control group, the recanalization rate was 58% and the recanalization rate was 76% in the study group. The recanalization rate in the study group was significantly higher than that in the control group. In the control group, there were 16 complications and 5 deaths. There were 9 complications and 3 deaths. The complications and death cases in the study group were lower than those in the control group. There was significant difference between the two groups (P <0.05). Conclusion Compared with conventional drug therapy, the clinical curative effect of thrombolytic therapy for acute myocardial infarction is more significant and worthy of promotion.